Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.

By Stephen T. Sonis, G. Oster, H. Fuchs, L. Bellm, W. Z. Bradford, J. Edelsberg, Vanessa Hayden, J. Eilers, J. Epstein, F. Leveque and 5 more. Journal of Clinical Oncology, 2001

655 citations recorded by the source corpus.

Subfields: Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/98d35f5bd2f301d4b22c91c543d14acfb7e578d7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. R. Lalla
2. J. Bowen
3. A. Barasch
4. O. Nicolatou‐Galitis
5. J. Raber-Durlacher
6. Stephen T Sonis
7. J. Epstein
8. Douglas E. Peterson

Citations in the corpus

• Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis (2004, neutral): “During the last 5 years, new models of the basic mechanisms of progression and healing and proposals for new research and treatment strategies have emerged.(1,3) Biotechnology and pharmaceutical industry researchers have joined academic clinical investigators in their attempts to develop interventio”
• MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy (2014, positive): “4424 Cancer October 1, 2020 eating and swallowing, the need for enteral or parenteral nutrition, increased opioid consumption, and interruptions to cancer therapy.(1,2) In immunosuppressed patients, OM is associated with bacteremia, increased inpatient hospitalization duration, and higher 100-day mo”